2016
DOI: 10.1002/jbmr.3055
|View full text |Cite
|
Sign up to set email alerts
|

Evidence of Staphylococcus Aureus Deformation, Proliferation, and Migration in Canaliculi of Live Cortical Bone in Murine Models of Osteomyelitis

Abstract: While Staphylococcus aureus osteomyelitis is considered to be incurable, the major bacterial reservoir in live cortical bone has remained unknown. In addition to biofilm bacteria on necrotic tissue and implants, studies have implicated intracellular infection of osteoblasts and osteocytes as a mechanism of chronic osteomyelitis. Thus, we performed the first systematic transmission electron microscopy (TEM) studies to formally define major reservoirs of S. aureus in chronically infected mouse (Balb/c J) long bo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
151
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 202 publications
(156 citation statements)
references
References 26 publications
4
151
0
1
Order By: Relevance
“…Staphylococcus aureus is responsible for the majority of chronic osteomyelitis cases; and these bone infections remain a major challenge in orthopaedics . Additionally, these infections are considered to be incurable due to biofilm dwelling bacteria that persist within Staphylococcus abscess communities (SACs or Brodie's abscesses) and deep within cortical bone; and costing billions of dollars each year . Of particular concern is the community‐associated methicillin‐resistant S. aureus (MRSA) strain USA300 LAC, which now accounts for the majority of orthopaedic infections .…”
Section: Introductionmentioning
confidence: 99%
“…Staphylococcus aureus is responsible for the majority of chronic osteomyelitis cases; and these bone infections remain a major challenge in orthopaedics . Additionally, these infections are considered to be incurable due to biofilm dwelling bacteria that persist within Staphylococcus abscess communities (SACs or Brodie's abscesses) and deep within cortical bone; and costing billions of dollars each year . Of particular concern is the community‐associated methicillin‐resistant S. aureus (MRSA) strain USA300 LAC, which now accounts for the majority of orthopaedic infections .…”
Section: Introductionmentioning
confidence: 99%
“…Once freed, these bacteria can cause a relapse in infection. Interestingly, de Mesy Bentley et al demonstrated the presence of significant colonies of S. aureus within the canaliculi of live cortical bone. While they show evidence of invasion of the canaliculi by infecting bacteria, it is also possible that some of those bacteria found within the canalicular system arose from infected bone cells.…”
Section: Discussionmentioning
confidence: 99%
“…Staphylococcus aureus, the most common pathogen identified in orthopaedic infections, 4 has been shown to invade osteoblasts in vitro, [5][6][7][8][9] as well as other eukaryotic cells. [10][11][12][13][14][15][16][17] In vivo, S. aureus has been found internalized in osteoblasts, both in an experimental chick embryo infection model 18 and in a patient with OM, 19 as well as closely associated with bone cells within the canaliculi of bone, both in a chronically infected mouse model, 20 as well as in a patient with an infected diabetic foot ulcer. 21 It has been suggested that such an evasive strategy would allow a pathogen a location safe from both the immune system and those antibiotics incapable of crossing the cell membrane.…”
mentioning
confidence: 99%
“…The failure rate of PJI treatment remains high despite surgical debridement, prosthetic exchange, and targeted systemic antimicrobial agents. Emerging antibiotic resistance, the formation of biofilm, and migration of bacteria to immune‐privileged locations such as the osteocyte lacuna‐canalicular network all contribute to the challenge of treating these infections 105–107 . A summary of promising treatment strategies in PJI is shown in Table 3.…”
Section: New Advancements In the Treatment Of Musculoskeletal Infectionmentioning
confidence: 99%